Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients Undergoing Coronary Angiography and/or Intervention

NCT00345501 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

208

Enrollment

OTHER

Sponsor class

Conditions

Renal Insufficiency, Chronic
Coronary Angiography
Angioplasty, Transluminal, Percutaneous Coronary

Interventions

DRUG: Iloprost
DRUG: Placebo

Sponsor

Onassis Cardiac Surgery Centre